Revolution Medicines (RVMD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist

57.850
-0.730-1.25%

Close Nov 29 13:00 ET

57.500
-0.350-0.61%

Post 17:01 ET

9.73BMarket Cap-15806P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Seeking AlphaNov 25 13:58 ET
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Seeking AlphaNov 19 11:06 ET
BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating
Moomoo NewsNov 15 09:31 ET · Ratings
Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight
Yahoo FinanceNov 9 00:05 ET
J.P. Morgan Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $63
Moomoo NewsNov 8 10:31 ET · Ratings
BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $80
Moomoo NewsNov 8 10:31 ET · Ratings

Comments

Stock_Drift

Oct 25 04:44

$Revolution Medicines (RVMD.US)$

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Jerry Kronenberg

Apr 10 15:11

Columns Revolution Medicines Gains 10%+ on Word of Experimental Anti-Tumor Drug

$Revolution Medicines (RVMD.US)$ rose more than 10% Wednesday after the biotech firm reported the discovery and preclinical-to-clinical translation of its anti-tumor drug RMC-6236.
RVMD gained 10.6% to close at $36.50 on word of the experimental drug, which the company disclosed in the publication Cancer Discovery.
Revolution disclosed news of the drug on Tuesday shortly before the market closed, sending shares up 3.4% that da...